These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 12394784)
1. Molecular basis for interactions of HIV and drugs of abuse. Nath A; Hauser KF; Wojna V; Booze RM; Maragos W; Prendergast M; Cass W; Turchan JT J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S62-9. PubMed ID: 12394784 [TBL] [Abstract][Full Text] [Related]
2. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650 [TBL] [Abstract][Full Text] [Related]
3. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]. Merino JJ; Montes ML; Blanco A; Bustos MJ; Oreja-Guevara C; Bayon C; Cuadrado A; Lubrini G; Cambron I; Munoz A; Cebolla S; Gutierrez-Fernandez M; Bernardino JI; Arribas JR; Fiala M Rev Neurol; 2011 Jan; 52(2):101-11. PubMed ID: 21271550 [TBL] [Abstract][Full Text] [Related]
4. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia. Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933 [TBL] [Abstract][Full Text] [Related]
5. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Theodore S; Cass WA; Nath A; Maragos WF Curr HIV Res; 2007 May; 5(3):301-13. PubMed ID: 17504172 [TBL] [Abstract][Full Text] [Related]
6. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. Turchan J; Anderson C; Hauser KF; Sun Q; Zhang J; Liu Y; Wise PM; Kruman I; Maragos W; Mattson MP; Booze R; Nath A BMC Neurosci; 2001; 2():3. PubMed ID: 11252157 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Silverstein PS; Shah A; Weemhoff J; Kumar S; Singh DP; Kumar A Curr HIV Res; 2012 Jul; 10(5):369-83. PubMed ID: 22591361 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction. Nath A Ann N Y Acad Sci; 2010 Feb; 1187():122-8. PubMed ID: 20201849 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine. Nair MP; Samikkannu T Curr HIV Res; 2012 Jul; 10(5):429-34. PubMed ID: 22591367 [TBL] [Abstract][Full Text] [Related]
12. Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. Haughey NJ; Mattson MP J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S55-61. PubMed ID: 12394783 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Theodore S; Cass WA; Maragos WF Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084 [TBL] [Abstract][Full Text] [Related]
14. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons. Teodorof-Diedrich C; Spector SA J Virol; 2018 Nov; 92(22):. PubMed ID: 30158296 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Theodore S; Cass WA; Nath A; Steiner J; Young K; Maragos WF Neurobiol Dis; 2006 Sep; 23(3):663-8. PubMed ID: 16828290 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368 [TBL] [Abstract][Full Text] [Related]
17. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Aksenov MY; Aksenova MV; Nath A; Ray PD; Mactutus CF; Booze RM Neurotoxicology; 2006 Mar; 27(2):217-28. PubMed ID: 16386305 [TBL] [Abstract][Full Text] [Related]
18. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221 [TBL] [Abstract][Full Text] [Related]
19. Opiate drug use and the pathophysiology of neuroAIDS. Hauser KF; Fitting S; Dever SM; Podhaizer EM; Knapp PE Curr HIV Res; 2012 Jul; 10(5):435-52. PubMed ID: 22591368 [TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Bansal AK; Mactutus CF; Nath A; Maragos W; Hauser KF; Booze RM Brain Res; 2000 Oct; 879(1-2):42-9. PubMed ID: 11011004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]